Literature DB >> 7092504

Public judgments of information in a diazepam patient package insert.

S Fisher, B Mansbridge, D A Lankford.   

Abstract

As part of a larger study of the effects of giving patients written take-home information with prescription medications, a "patient package insert" (PPI) for diazepam was prepared based on content determined by "experts." This report compares the experts' judgments of what information should be included with judgments obtained from the public. Information judged to be most important for inclusion in a PPI was identified by having subjects sort cards containing facts about diazepam. Subjects who had previously used diazepam were no different in their judgments than inexperienced subjects. In general, there was a high degree of concordance between public and expert judgments and also a remarkably strong consensus across very different demographic samples. In those few instances of disagreement, the public attached even greater importance to warnings and "bad news" about diazepam than to information providing reassurances, benign general education, and "good news." To what extent patients would effectively use this information--whether conveyed by PPIs or alternative educational routes--must await empirical evaluation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092504     DOI: 10.1001/archpsyc.1982.04290060055011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  3 in total

Review 1.  The role and value of written information for patients about individual medicines: a systematic review.

Authors:  Janet Grime; Alison Blenkinsopp; David K Raynor; Kristian Pollock; Peter Knapp
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

2.  Patient information leaflets.

Authors:  V W Drury
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

3.  Public knowledge and attitudes about diazepam.

Authors:  B Mansbridge; S Fisher
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.